- Stocks
- Pharma & Healthcare
- Asston Pharma
Asston Pharma share price
NSE: APLPharma & HealthcareDrug Manufacturers - Specialty & Generic
Asston Pharma at a glance
With a market capitalisation of ₹69 Cr, it ranks 2883rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Promoters held 50.66% of the company as of 31 Mar 2026.
Key numbers
- Market cap
- ₹69 CrRank 2883 on NSE
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Asston Pharma shareholding pattern
| Holder | 17 Jul 2025 | 30 Sep 2025 | 31 Mar 2026 |
|---|---|---|---|
| Promoters | 50.66% | 50.66% | 50.66% |
| Foreign institutions | 9.70% | 6.04% | 1.91% |
| Non-institutions | 35.56% | 43.30% | 47.42% |
Asston Pharma vs peers
The listed Pharma & Healthcare companies nearest to Asston Pharma by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| METSLMaestros Elect | — | — | — | ₹76 Cr | — | — |
| BIBCLBharat Immuno | — | — | — | ₹75 Cr | — | — |
| SOURCENTRLSource Natural | — | — | — | ₹70 Cr | — | — |
| APLAsston Pharma | — | — | — | ₹69 Cr | — | — |
| FERVENTSYNFervent Synergi | — | — | — | ₹68 Cr | — | — |
| SUNLOCSunil Health | ₹65.00 | 0.00% | — | ₹67 Cr | 16.6 | — |
| SAMRATPHSamrat Pharma | — | — | — | ₹61 Cr | — | — |
Ask anything about Asston Pharma
Pivot answers on the live chart with evidence you can check, and tests strategies against APL's own history. Try: “Why has APL moved over the last three months?” · “Backtest a 50-day moving-average crossover on APL over five years” · “Compare APL with METSL on margins and valuation”
Frequently asked questions about Asston Pharma
What is the market cap of Asston Pharma?
Asston Pharma's market capitalisation is ₹69 Cr (₹69 Cr) at the 22 Oct 2026 close, ranking 2883rd among the NSE companies Pivot tracks.
What is the shareholding pattern of Asston Pharma?
As of 31 Mar 2026: promoters 50.66%, foreign institutions 1.91%, non-institutions 47.42%.
Who are Asston Pharma's competitors?
The listed Pharma & Healthcare companies closest to Asston Pharma by market cap are Maestros Elect, Bharat Immuno, Source Natural, Fervent Synergi, Sunil Health and Samrat Pharma.
Is Asston Pharma a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Asston Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on APL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text